Janssen - Johnson & Johnson COVID-19 Vaccine
Jeneng umum: COVID-19 (coronavirus 2019) Vaccine, Janssen - Johnson & Johnson (KOE Vid (koe ROE Na Vye Rus) VAX Een)
Jeneng merek: Janssen COVID-19 Vaccine PF
Kelas obat:
Vaksin virus
Panganggone Janssen - Johnson & Johnson COVID-19 Vaccine
Diterusake. FDA mbatalake wewenang panggunaan darurat (EUA) kanggo Vaksin COVID-19 Janssen ing Kamis, 1 Juni 2023, sawise panjaluk Janssen. Akeh vaksin pungkasan wis kadaluwarsa, ora ana panjaluk kanggo akeh vaksin anyar ing AS, lan perusahaan ora pengin nganyari komposisi galur vaksin iki kanggo ngatasi varian sing muncul. Informasi iki disimpen ing kene kanggo tujuan riset.
Vaksin Janssen COVID-19 bisa mbantu awak ngembangake kekebalan marang SARS-CoV-2. Nanging, vaksin iki durung disetujoni kanggo nyegah utawa ngobati coronavirus utawa COVID-19 lan wis ora kasedhiya maneh.
Vaksin Janssen COVID-19 digunakake ing wong sing umure 18 taun utawa luwih:
COVID-19 minangka penyakit serius sing disebabake dening coronavirus sing diarani SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). COVID-19 nyebar saka wong menyang wong liwat udhara.
COVID-19 bisa mengaruhi paru-paru utawa organ liyane. Gejala kasebut bisa entheng utawa serius lan kalebu mriyang, hawa adhem, watuk, lara tenggorokan, sesak ambegan, kesel, nyeri awak, sirah, ilang rasa utawa mambu, irung meler utawa tersumbat, mual, muntah, utawa diare.
Vaksin COVID-19 digunakake kanggo nyegah penyakit abot lan pati saka COVID-19 sing disebabake dening SARS-CoV-2.
Vaksin COVID-19 ora ngemot coronavirus lan ora bisa menehi sampeyan COVID- 19. Vaksin iki ora bakal nambani infeksi COVID-19 sing aktif.
Kaya vaksin apa wae, Vaksin COVID-19 Janssen bisa uga ora menehi perlindungan kanggo saben wong.
Janssen - Johnson & Johnson COVID-19 Vaccine efek sisih
Entuk bantuan medis darurat yen sampeyan duwe tandha reaksi alergi marang Vaksin COVID-19 Janssen: gatal-gatal; dizziness, kekirangan, deg-degan cepet; ambegan angel; bengkak ing rai, lambe, ilat, utawa tenggorokan.
Reaksi alergi luwih kerep kedadeyan sajrone sawetara menit nganti 1 jam sawise sampeyan nampa vaksin. Sampeyan bakal diobati kanthi cepet yen sampeyan duwe reaksi.
Infeksi COVID-19 luwih mbebayani kanggo kesehatan tinimbang nampa Vaksin COVID-19 Janssen.
Sawetara wong duwe getih. gumpalan 1 nganti 2 minggu sawise nampa Vaksin Janssen COVID-19, nanging risiko efek samping iki adoh banget. Langsung golek dhokter yen sampeyan duwe:
Sawetara wong sing nampa Vaksin COVID-19 Janssen duwe masalah sistem saraf. ing 42 dina sawise nampa vaksin iki, nanging risiko efek sisih iki banget kurang. Enggal golek pitulung medis yen sampeyan duwe:
Sindrom bocor kapiler minangka efek samping sing langka nanging serius. . Langsung nelpon dhokter yen sampeyan duwe tandha-tandha saka kondisi iki: irung tersumbat utawa meler banjur kesel, ngelak, kurang urination, alangan ambegan, lan dadakan dadi gedhe utawa tambah bobot.
Ora kabeh efek samping bisa dingerteni.
Efek samping vaksin Janssen COVID-19 sing umum bisa kalebu:
Efek samping liyane, entheng utawa serius, bisa kedadeyan kanthi nggunakake COVID- 19 vaksin.
Iki dudu dhaptar lengkap efek samping lan bisa uga kedadeyan. Telpon dhokter kanggo saran medis babagan efek samping. Sampeyan bisa uga nglaporake efek samping vaksin menyang Departemen Kesehatan lan Layanan Manungsa AS ing 1-800-822-7967.
Sampeyan uga bisa nggunakake program basis smartphone sing diarani V-safe kanggo komunikasi karo Centers for Kontrol lan Pencegahan Penyakit (CDC) babagan masalah kesehatan sing sampeyan alami sawise nampa vaksin COVID-19.
Sadurunge njupuk Janssen - Johnson & Johnson COVID-19 Vaccine
Sampeyan ora kudu nampa vaksin Janssen COVID-19 yen sampeyan nandhang reaksi alergi sawise dosis vaksin iki utawa yen sampeyan duwe gumpalan getih kanthi tingkat trombosit sing kurang sawise nampa vaksin iki utawa vaksin AstraZeneca COVID-19. (ora sah utawa disetujoni ing Amerika Serikat).
Yen sampeyan kena infeksi COVID-19, ngenteni asil tes, utawa katon karo wong sing kena infeksi COVID-19: Sampeyan bisa uga ora bisa nampa Vaksin COVID-19 Janssen nganti ora ana gejala lan/utawa periode karantina sing dibutuhake wis rampung. Nampa Vaksin Janssen COVID-19 ora bakal nggawe sampeyan kurang nular marang wong liya yen sampeyan kena infeksi COVID-19 nanging ora ana gejala.
Takon dhokter sampeyan yen sampeyan ora yakin babagan perawatan COVID-19 sing ditampa.
Kanggo mesthekake yen Vaksin Janssen COVID-19 aman kanggo sampeyan, hubungi dhokter sampeyan yen:
COVID-19 luwih bisa nyebabake penyakit serius utawa pati ing wanita ngandhut. Durung kabeh risiko dimangerteni, nanging Vaksin Janssen COVID-19 bisa uga kurang mbebayani tinimbang kena infeksi COVID-19 nalika meteng.
Yen sampeyan lagi mbobot, jeneng sampeyan bisa uga ana ing daftar meteng kanggo nglacak efek saka Vaksin COVID-19 Janssen marang bayi.
Related obat
- Abrysvo
- ACAM2000
- Adenovirus vaccine, live
- Afluria
- Afluria 2015-2016 Formula
- Afluria PF Pediatric Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2022-2023 injection
- Afluria PF Quadrivalent 2023-2024 injection
- Afluria Quadrivalent 2021-2022 injection
- Afluria Quadrivalent 2022-2023 injection
- Afluria Quadrivalent 2023-2024 injection
- Agriflu
- Arexvy
- Attenuvax
- Audenz
- Comirnaty
- Comirnaty (2023-2024) PF (cvx 309) 2023-2024
- COVID-19 (12y+) vaccine Spikevax 2023-2024
- COVID-19 (12y+) vaccine, Pfizer 2023-2024
- COVID-19 (5y-11y) vaccine, Pfizer 2023-2024
- COVID-19 (6m-11y) vaccine, Moderna 2023-2024
- COVID-19 (6m-4y) vaccine, Pfizer 2023-2024
- COVID-19 vaccine, Novavax (2023-2024)
- Mumps virus vaccine, live
- Mumpsvax
- Cervarix
- Dengue tetravalent vaccine, live
- Dengue vaccine
- Dengvaxia
- Dryvax
- Engerix-B
- Engerix-B (HepB)
- Engerix-B Pediatric
- Fluad
- Fluad 2017-2018 Formula
- Fluad Quadrivalent PF 2022-2023 injection
- Fluad Quadrivalent PF 2023-2024 injection
- Fluarix PF Quadrivalent 2021-2022 injection
- Fluarix PF Quadrivalent 2022-2023 injection
- Fluarix PF Quadrivalent 2023-2024 injection
- Fluarix Quadrivalent
- Fluarix Quadrivalent 2013-2014 Formula
- Fluarix Quadrivalent 2015-2016 Formula
- Flublok 2015-2016 Formula
- Flublok 2016-2017 Formula
- Flublok 2017-2018 Formula
- Flublok Quadrivalent
- Flublok Quadrivalent 2016-2017 Formula
- Flublok Quadrivalent 2017-2018 Formula
- Flublok Quadrivalent 2021-2022 injection
- Flublok Quadrivalent 2022-2023 injection
- Flublok Quadrivalent 2023-2024 injection
- Flucelvax 2015-2016 Formula
- Flucelvax PF Quadrivalent 2021-2022 injection
- Flucelvax PF Quadrivalent 2022-2023 injection
- Flucelvax PF Quadrivalent 2023-2024 injection
- Flucelvax Quadrivalent
- Flucelvax Quadrivalent 2021-2022 injection
- Flucelvax Quadrivalent 2022-2023 injection
- Flucelvax Quadrivalent 2023-2024 injection
- FluLaval PF Quadrivalent 2021-2022 injection
- FluLaval PF Quadrivalent 2022-2023 injection
- FluLaval PF Quadrivalent 2023-2024 injection
- Flulaval Quadravalent 2013-2014 Season
- FluLaval Quadrivalent
- FluLaval Quadrivalent 2015-2016 Formula
- Flumist
- FluMist Quadrivalent 2015-2016 Formula
- FluMist Quadrivalent 2023-2024 nasal
- Fluvirin 2015-2016 Formula
- Fluzone 2013-2014 Formula
- Fluzone 2015-2016 Formula
- Fluzone High Dose 2015-2016 Formula
- Fluzone High-Dose Quadrivalent PF 2021-2022 injection
- Fluzone High-Dose Quadrivalent PF 2022-2023 injection
- Fluzone High-Dose Quadrivalent PF 2023-2024 injection
- Fluzone Intradermal Quadrivalent 2014-2015 Formula
- Fluzone Intradermal Quadrivalent 2015-2016 Formula
- Fluzone PF Pediatric Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2022-2023 injection
- Fluzone PF Quadrivalent 2023-2024 injection
- Fluzone Quadrivalent
- Fluzone Quadrivalent 2021-2022 injection
- Fluzone Quadrivalent 2022-2023 injection
- Fluzone Quadrivalent 2023-2024 injection
- Gardasil 9
- Gardasil 9 Vaccine
- Havrix
- Havrix Pediatric
- Hepatitis A adult vaccine
- Hepatitis A pediatric vaccine
- Hepatitis a vaccine
- Hepatitis B adult vaccine
- Hepatitis B pediatric vaccine
- Hepatitis b vaccine
- Hepatitis b vaccine recombinant, adjuvanted
- Heplisav-B
- Human papillomavirus (HPV) vaccine, 9-valent
- Human papillomavirus vaccine
- Imovax Rabies human diploid cell
- Influenza A (H1N1) 2009 Monovalent Vaccine
- Influenza a virus vaccine, h1n1, inactivated
- Influenza a virus vaccine, h5n1, adjuvanted
- Influenza virus vaccine
- Influenza virus vaccine injection
- Influenza virus vaccine nasal
- Influenza virus vaccine recombinant
- Influenza virus vaccine, adjuvanted
- Influenza Virus Vaccine, H5N1
- Influenza virus vaccine, live
- Ipol
- Ixiaro
- Janssen - Johnson & Johnson COVID-19 Vaccine
- Japanese encephalitis virus vaccine SA14-14-2
- Jynneos
- Measles virus vaccine, live
- Meruvax II
- Moderna COVID-19 (2023-2024) PF Vaccine (cvx 311) 2023-2024
- Moderna COVID-19 Vaccine
- Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) 2023-2024
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) 2023-2024
- Pfizer-BioNTech COVID-19 Vaccine
- Polio vaccine, inactivated
- Poliovirus vaccine, inactivated
- PreHevbrio
- RabAvert purified chick embryo cell
- Rabies vaccine human diploid cell
- Rabies vaccine purified chick embryo cell
- Recombivax HB
- Recombivax HB Adult
- Recombivax HB Dialysis Formulation
- Recombivax HB Pediatric/Adolescent
- Respiratory syncytial virus (RSV) vaccine
- Respiratory syncytial virus vaccine
- Respiratory syncytial virus vaccine, adjuvanted
- Rotarix
- Rotateq
- Rotavirus vaccine, live
- Rubella virus vaccine, live
- Sars-cov-2 (covid-19) vaccine, adenovirus 26 vector (janssen)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (moderna)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (pfizer)
- Sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (moderna)
- Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
- Shingrix
- Smallpox and monkeypox vaccine
- Smallpox monkeypox vaccine, live non-replicating
- Smallpox vaccine
- Spikevax
- Spikevax (2023-2024) PF (cvx 312) 2023-2024
- Tick-borne encephalitis pediatric vaccine
- Tick-borne encephalitis vaccine
- TicoVac
- TicoVac Pediatric
- Vaqta
- Vaqta Pediatric
- Varicella virus (chickenpox) vaccine
- Varicella virus vaccine, live
- Varivax
- Yellow fever vaccine
- YF-Vax
- Zostavax
- Zoster vaccine inactivated
- Zoster vaccine recombinant, adjuvanted
- Zoster vaccine, live
Carane nggunakake Janssen - Johnson & Johnson COVID-19 Vaccine
Dosis Dewasa Biasa kanggo COVID-19:
0,5 mL IM sapisan.
FDA wis ngetokake EUA kanggo dosis booster siji. diwenehi paling sethithik 2 sasi sawise dosis utama, kanggo wong sing umure 65 taun lan luwih lawas, lan wong umur 18 - 64 taun sing duwe risiko dhuwur kanggo COVID-19 abot; lan individu umur 18 - 64 taun sing asring paparan institusi utawa pekerjaan marang SARS-CoV-2 nyebabake risiko komplikasi serius saka COVID-19 kalebu COVID-19 sing abot.
Komentar: -Vaksin iki ora disetujoni dening FDA kanggo nyegah COVID-19. FDA wis ngetokake EUA kanggo nggunakake vaksin iki. -Ora ana data sing kasedhiya babagan panggunaan Vaksin COVID-19 Janssen kanggo ngrampungake seri vaksin penyakit koronavirus 2019 (COVID-19) sing diwiwiti karo vaksin liyane. Gunakake: Imunisasi aktif kanggo nyegah penyakit COVID-19 sing disebabake dening SARS-CoV-2
Pènget
Sawetara wong ngalami gumpalan getih sawise nampa vaksin iki, nanging risiko efek samping iki adoh banget. Infèksi COVID-19 luwih mbebayani kanggo kesehatan tinimbang nampa Vaksin COVID-19 Janssen.
Apa obatan liyane bakal mengaruhi Janssen - Johnson & Johnson COVID-19 Vaccine
Sadurunge nampa Vaksin COVID-19 Janssen, ucapake panyedhiya vaksinasi babagan kabeh vaksin liyane sing wis ditampa lan kabeh obat sing digunakake. Iki kalebu obat-obatan resep lan over-the-counter, vitamin, lan produk herbal.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions